Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Janney Montgomery Scott LLC lowered its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 21.0% in the fourth quarter, ...

Many leading pharma and biotechs have invested in messenger RNA (mRNA) technology to develop COVID-19 vaccines and are now exploring their potential in other disease areas (Figure 1). The success ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...

Wang, Alex Kim, and Kevin Kim found that genetic DNA mutations contaminated some severe acute respiratory syndrome coronavirus 2 messenger RNA vaccines, called mRNA, which use messenger RNA ...

The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...

such as better treatments for hemophilia and cheaper vaccines. Let’s review how the technology works and the latest advancements in the field. RNA interference (RNAi) therapeutics are based on a ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Messenger RNA (mRNA) vaccines offer an adaptable and scalable platform for cancer immunotherapy, requiring optimal design to elicit a robust and targeted immune response. Recent advancements in ...